These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 35130731)

  • 1. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
    Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
    Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon Cancer-Associated
    Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
    Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Brennan CA; Clay SL; Lavoie SL; Bae S; Lang JK; Fonseca-Pereira D; Rosinski KG; Ou N; Glickman JN; Garrett WS
    Gut Microbes; 2021; 13(1):1987780. PubMed ID: 34781821
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients.
    Tran HNH; Thu TNH; Nguyen PH; Vo CN; Doan KV; Nguyen Ngoc Minh C; Nguyen NT; Ta VND; Vu KA; Hua TD; Nguyen TNT; Van TT; Pham Duc T; Duong BL; Nguyen PM; Hoang VC; Pham DT; Thwaites GE; Hall LJ; Slade DJ; Baker S; Tran VH; Chung The H
    NPJ Biofilms Microbiomes; 2022 Oct; 8(1):87. PubMed ID: 36307484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
    Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
    Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with
    Borozan I; Zaidi SH; Harrison TA; Phipps AI; Zheng J; Lee S; Trinh QM; Steinfelder RS; Adams J; Banbury BL; Berndt SI; Brezina S; Buchanan DD; Bullman S; Cao Y; Farris AB; Figueiredo JC; Giannakis M; Heisler LE; Hopper JL; Lin Y; Luo X; Nishihara R; Mardis ER; Papadopoulos N; Qu C; Reid EEG; Thibodeau SN; Harlid S; Um CY; Hsu L; Gsur A; Campbell PT; Gallinger S; Newcomb PA; Ogino S; Sun W; Hudson TJ; Ferretti V; Peters U
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):210-220. PubMed ID: 34737207
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Engevik MA; Danhof HA; Ruan W; Engevik AC; Chang-Graham AL; Engevik KA; Shi Z; Zhao Y; Brand CK; Krystofiak ES; Venable S; Liu X; Hirschi KD; Hyser JM; Spinler JK; Britton RA; Versalovic J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33653893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Based Reclassification of Fusobacterium nucleatum Subspecies at the Species Level.
    Kook JK; Park SN; Lim YK; Cho E; Jo E; Roh H; Shin Y; Paek J; Kim HS; Kim H; Shin JH; Chang YH
    Curr Microbiol; 2017 Oct; 74(10):1137-1147. PubMed ID: 28687946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.